Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took two doses of Vivotif correctly, it was some time last week and had a lapse in days; Case reference number US-BN-2025-001495 is a spontaneous case initially received from pharmacist via Communication (reference number: USBAV25-2181) on 02-Sep-2025 and concerns a 30-years-old female patient. The patient's medical history and concomitant medication were not provided. On an unspecified date, the patient took the first dose of Vivotif vaccine (batch number: unknown) at unknown dose, orally for indication of typhoid immunization. On an unspecified date, an unknown amount of time from the first dose, the patient took the second dose of Vivotif vaccine (batch number: unknown) at unknown dose, orally. As reported, the patient took two doses correctly (reported as sometime last week) and had a lapse in days and now will be able to continue after x number of days (explicitly coded as 'incomplete course of administration'). At the time of the initial report, the patient had not experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A 30-year-old female patient took two doses of Vivotif for indication of typhoid immunization correctly (reported as sometime last week) and had a lapse in days and now will be able to continue after x number of days, which is considered as incomplete course of administration. The patient had not experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 30-year-old female patient took two doses of Vivotif for indication of typhoid immunization correctly (reported as sometime last week) and had a lapse in days and now will be able to continue after x number of days, which is considered as incomplete course of administration. The patient had not experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE